Stimulated Thyroglobulin and Pre-ablation Antithyroglobulin Antibody Product Can Predict the Response to Radioiodine Therapy in TgAb-positive Differentiated Thyroid Cancer Pa-tients: A Retrospective Study
Abstract:Objective We aimed to explore the predictive value of stimulated thyroglobulin(sTg) and pre-ablation antithyroglobulin (paTgAb) product to the effect of radioiodine therapy (RAIT) in TgAb-positive DTC patients.Methods We totally enrolled 265 patients with TgAb-positive DTC who underwent RAIT after total thyroidectomy (TT) in this study. Based on the last follow-up result, patients were divided into two groups, which were excellent response (ER) group and non-excellent response (NER) group. We analyzed the fact… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.